Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study

Andrew Scholey, Anastasia Ossoukhova, Lauren Owen, Alvin Ibarra, Andrew Pipingas, Kan He, Marc Roller, Con Stough, Andrew Scholey, Anastasia Ossoukhova, Lauren Owen, Alvin Ibarra, Andrew Pipingas, Kan He, Marc Roller, Con Stough

Abstract

Rationale: Over the last decade, Asian ginseng (Panax ginseng) has been shown to improve aspects of human cognitive function. American ginseng (Panax quinquefolius) has a distinct ginsenoside profile from P. ginseng, promising cognitive enhancing properties in preclinical studies and benefits processes linked to human cognition.

Objectives: The availability of a highly standardised extract of P. quinquefolius (Cereboost™) led us to evaluate its neurocognitive properties in humans for the first time.

Methods: This randomised, double-blind, placebo-controlled, crossover trial (N = 32, healthy young adults) assessed the acute mood, neurocognitive and glycaemic effects of three doses (100, 200 400 mg) of Cereboost™ (P. quinquefolius standardised to 10.65% ginsenosides). Participants' mood, cognitive function and blood glucose were measured 1, 3 and 6 h following administration.

Results: There was a significant improvement of working memory (WM) performance associated with P. quinquefolius. Corsi block performance was improved by all doses at all testing times. There were differential effects of all doses on other WM tasks which were maintained across the testing day. Choice reaction time accuracy and 'calmness' were significantly improved by 100 mg. There were no changes in blood glucose levels.

Conclusions: This preliminary study has identified robust working memory enhancement following administration of American ginseng. These effects are distinct from those of Asian ginseng and suggest that psychopharmacological properties depend critically on ginsenoside profiles. These results have ramifications for the psychopharmacology of herbal extracts and merit further study using different dosing regimens and in populations where cognition is fragile.

Figures

Fig. 1
Fig. 1
a Chromatogram of the American ginseng (Panax quinquefolius) extract. b Structures of ginsenosides
Fig. 2
Fig. 2
Significant effects of Panax quinquefolius on cognitive function and mood. Graphs depict mean change-from-baseline scores following a placebo and 100, 200 and 400 mg of a standardised extract. Significant differences from placebo at each time point are indicated (*p < 0.05, see text for details)

References

    1. Abe K, Cho S, Kitagawa I, Nishiyama N, Saito H. Differential effects of ginsenoside Rb1 and malonylginsenoside Rb1 on long-term potentiation in the dentate gyrus of rats. Brain Res. 1994;649:7–11. doi: 10.1016/0006-8993(94)91042-1.
    1. Ahern EP. The use of visual analogue scales in mood disorders: a critical review. J Psychiatr Res. 1997;31:569–579. doi: 10.1016/S0022-3956(97)00029-0.
    1. Antony M, Bieling P, Cox B, Enns M, Swinson R. Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychol Assess. 1998;10:176–181. doi: 10.1037/1040-3590.10.2.176.
    1. Axmacher N, Lenz S, Haupt S, Elger C, Fell J. Electrophysiological signature of working and long-term memory interaction in the human hippocampus. Eur J Neurosci. 2009;31:177–188. doi: 10.1111/j.1460-9568.2009.07041.x.
    1. Benishin C. Actions of ginsenoside Rb1 on choline uptake in central cholinergic nerve endings. Neurochem Int. 1992;21:1–5. doi: 10.1016/0197-0186(92)90061-U.
    1. Benishin CG, Lee R, Wang LCH, Liu HJ. Effects of ginsenoside Rb 1 on central cholinergic metabolism. Pharmacology. 1991;42:223–229. doi: 10.1159/000138801.
    1. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psychol. 1974;47:211–218.
    1. Chen X, Li Y, Deng H, Yang B, Li D, Shen N. Protective effects of ginsenosides on anoxia/reoxygenation of cultured rat myocytes and on reperfusion injuries against lipid peroxidation. Biomed Biochim Acta. 1987;46:S646.
    1. Choi S, Saji H, Iida Y, Magata Y, Yokoyama A. Ginseng pretreatment protects against transient global cerebral ischemia in the rat: measurement of local cerebral glucose utilization by [14C] deoxyglucose autoradiography. Biol Pharm Bull. 1996;19:644.
    1. Donohoe R, Benton D. Cognitive functioning is susceptible to the level of blood glucose. Psychopharmacology. 1999;145:378–385. doi: 10.1007/s002130051071.
    1. Donohoe R, Benton D. Declining blood glucose levels after a cognitively demanding task predict subsequent memory. Nutr Neurosci. 1999;2:413–424.
    1. Durgnat J, Heuser J, Andrey D, Perrin C. Quality and safety assessment of ginseng extracts by determination of the contents of pesticides and metals. Food Addit Contam: Part A. 2005;22:1224–1230. doi: 10.1080/02652030500199439.
    1. Eichenbaum H, Cohen NJ. From conditioning to conscious recollection: memory systems of the brain. London, Uk: Oxford University Press; 2001.
    1. Gabrieli J, Poldrack R, Desmond J. The role of left prefrontal cortex in language and memory. Proc Natl Acad Sci. 1998;95:906. doi: 10.1073/pnas.95.3.906.
    1. Giovannini MG, Camilli F, Mundula A, Bianchi L, Colivicchi MA, Pepeu G. Differential regulation by N-methyl–aspartate and non-N-methyl–aspartate receptors of acetylcholine release from the rat striatum in vivo. Neuroscience. 1995;65:409–415. doi: 10.1016/0306-4522(94)00503-W.
    1. Goldman-Rakic P, Cools A, Srivastava K. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive [and Discussion] Philos Trans: Biol Sci. 1996;351:1445–1453. doi: 10.1098/rstb.1996.0129.
    1. Harkey M, Henderson G, Gershwin M, Stern J, Hackman R. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr. 2001;73:1101.
    1. Haskell C, Kennedy D, Wesnes K, Milne A, Scholey A. A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guaraná in humans. J Psychopharmacol Oxf Engl. 2007;21:65. doi: 10.1177/0269881106063815.
    1. Hiai S, Yokoyama H, Oura H, Kawashima Y. Evaluation of corticosterone secretion-inducing activities of ginsenosides and their prosapogenins and sapogenins. Chem Pharm Bull. 1983;31:168.
    1. Jin S, Park J, Nam K, Park S, Jung N. Korean red ginseng saponins with low ratios of protopanaxadiol and protopanaxatriol saponin improve scopolamine-induced learning disability and spatial working memory in mice. J Ethnopharmacol. 1999;66:123–129. doi: 10.1016/S0378-8741(98)00190-1.
    1. Kang S, Schini-Kerth V, Kim N. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Life Sci. 1995;56:1577–1586. doi: 10.1016/0024-3205(95)00124-O.
    1. Kennedy D, Scholey A. Glucose administration, heart rate and cognitive performance: effects of increasing mental effort. Psychopharmacology. 2000;149:63–71. doi: 10.1007/s002139900335.
    1. Kennedy D, Scholey A. Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav. 2003;75:687–700. doi: 10.1016/S0091-3057(03)00126-6.
    1. Kennedy D, Scholey A, Wesnes K. Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers. Nutr Neurosci. 2001;4:399–412.
    1. Kennedy D, Scholey A, Wesnes K. Dose dependent changes in cognitive performance and mood following acute administration of ginseng to healthy young volunteers. Nutr Neurosci. 2001;4:295–310.
    1. Kennedy D, Scholey A, Wesnes K. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiol Behav. 2002;75:739–752. doi: 10.1016/S0031-9384(02)00665-0.
    1. Kennedy D, Wake G, Savelev S, Tildesley N, Perry E, Wesnes K, Scholey A. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. 2003;28:1871–1881. doi: 10.1038/sj.npp.1300230.
    1. Keppel G. Design and analysis. A researcher’s handbook. 3. Englewood Cliffs, NJ: Prentice-Hall; 1991.
    1. Kim D, Jung J, Suh H, Huh S, Min S, Son B, Park J, Kim N, Kim Y, Song D. Inhibition of stress-induced plasma corticosterone levels by ginsenosides in mice: involvement of nitric oxide. NeuroReport. 1998;9:2261. doi: 10.1097/00001756-199807130-00021.
    1. Kim H, Hong Y, Oh K, Seong Y, Rheu H, Cho D, Oh S, Park W, Jang C. Inhibition by ginsenosides Rb1 and Rg1 of methamphetamine-induced hyperactivity, conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Gen Pharmacol. 1998;30:783–789. doi: 10.1016/S0306-3623(97)00330-3.
    1. Lewis R, Wake G, Court G, Court JA, Pickering AT, Kim YC, Perry EK. Non-ginsenoside nicotinic activity in ginseng species. Phytother Res. 1999;13:59–64. doi: 10.1002/(SICI)1099-1573(199902)13:1<59::AID-PTR423>;2-K.
    1. Lezak M, Loring D. Neuropsychological assessment. New York: Oxford University Press; 2004.
    1. Lezak M, Howieson D, Loring D. Neuropsychological assessment. New York: Oxford University Press; 1995.
    1. Lovibond P, Lovibond S. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther. 1995;33:335–343. doi: 10.1016/0005-7967(94)00075-U.
    1. Luo Y, Cheng X, Yuan W. Effects of ginseng root saponins and ginsenoside Rb1 on immunity in cold water swim stress mice and rats. Zhongguo Yao Li Xue Bao. 1993;14:401–404.
    1. MacLeod C. The Stroop task: the“gold standard” of attentional measures. J Exp Psychol Gen. 1992;121:12–14. doi: 10.1037/0096-3445.121.1.12.
    1. Martinez B, Staba E. The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats. Jpn J Pharmacol. 1984;35:79.
    1. Matthews D, Holman R, Bown E, Steemson J, Watson A, Hughes S, Scott D. Pen-sized digital 30-second blood glucose meter. Lancet. 1987;1:778. doi: 10.1016/S0140-6736(87)92802-9.
    1. Oshima Y, Sato K, Hikino H. Isolation and hypoglycemic activity of quinquefolans A, B, and C, glycans of Panax quinquefolium roots. J Nat Prod. 1987;50:188–190. doi: 10.1021/np50050a010.
    1. Petkov V. Ginseng as a remedy regulating aging process in brain (experiments of rats) In: Shibata YOaHS S, editor. Recent advances in ginseng study. Tokyo: Hirokawa; 1990. pp. 83–98.
    1. Prast H, Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol. 2001;64:51–68. doi: 10.1016/S0301-0082(00)00044-7.
    1. Reay J, Kennedy D, Scholey A. Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. J Psychopharmacol. 2005;19:357. doi: 10.1177/0269881105053286.
    1. Reay J, Kennedy D, Scholey A. Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained’mentally demanding’tasks. J Psychopharmacol. 2006;20:771. doi: 10.1177/0269881106061516.
    1. Reay J, Scholey AB, Kennedy DO (2010) Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults. Hum Psychopharmacol: Clin Exp in press doi:10.1002/hup.1138
    1. Reich E, Schibli A. High-performance thin-layer chromatography for the analysis of medicinal plants. New York: Thieme Medical Pub; 2006.
    1. Rudakewich M, Ba F, Benishin C. Neurotrophic and neuroprotective actions of ginsenosides Rb 1 and Rg 1. Planta Med. 2001;67:533–537. doi: 10.1055/s-2001-16488.
    1. Sala F, Mulet J, Choi S, Jung S, Nah S, Rhim H, Valor L, Criado M, Sala S. Effects of ginsenoside Rg2 on human neuronal nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 2002;301:1052. doi: 10.1124/jpet.301.3.1052.
    1. Salemme E, Diano S, Maharajan P, Maharajan V. Nitric oxide, a neuronal messenger. Riv Biol. 1996;89(1):87–107.
    1. Salim K, McEwen B, Chao H. Ginsenoside Rb1 regulates ChAT, NGF and trkA mRNA expression in the rat brain. Mol Brain Res. 1997;47:177–182. doi: 10.1016/S0169-328X(97)00042-9.
    1. Scholey A, Kennedy D. Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Hum Psychopharmacol: Clin Exp. 2002;17:35–44. doi: 10.1002/hup.352.
    1. Scholey A, Harper S, Kennedy D. Cognitive demand and blood glucose. Physiol Behav. 2001;73:585–592. doi: 10.1016/S0031-9384(01)00476-0.
    1. Scholey A, Kennedy D, Wesnes K. The psychopharmacology of herbal extracts: issues and challenges. Psychopharmacology. 2005;179:705–707. doi: 10.1007/s00213-004-2062-9.
    1. Scholey A, Tildesley N, Ballard C, Wesnes K, Tasker A, Perry E, Kennedy D. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology. 2008;198:127–139. doi: 10.1007/s00213-008-1101-3.
    1. Sloley B, Pang P, Huang B, Ba F, Li F, Benishin C, Greenshaw A, Shan J. American ginseng extract reduces scopolamine-induced amnesia in a spatial learning task. J Psychiatry Neurosci. 1999;24:442.
    1. Soldati F, Sticher O. HPLC separation and quantitative determination of ginsenosides from Panax ginseng, Panax quinquefolium and from ginseng drug preparations. Planta Med. 1980;39:348–357. doi: 10.1055/s-2008-1074929.
    1. Spielberger C, Jacobs G, Russell S, Crane R. Assessment of anger: the state-trait anger scale. Adv Pers Assess. 1983;2:159–187.
    1. Stough C, Lloyd J, Clarke J, Downey L, Hutchison C, Rodgers T, Nathan P, Ltd S. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl) 2001;156:481–484. doi: 10.1007/s002130100815.
    1. Stroop J. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643–662. doi: 10.1037/h0054651.
    1. Tachikawa E, Kudo K, Harada K, Kashimoto T, Miyate Y, Kakizaki A, Takahashi E. Effects of Ginseng saponins on responses induced by varoius receptor stimuli. Eur J Pharmacol. 1999;369:23–32. doi: 10.1016/S0014-2999(99)00043-6.
    1. Tildesley N, Kennedy D, Perry E, Ballard C, Wesnes K, Scholey A. Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiol Behav. 2005;83:699–709. doi: 10.1016/j.physbeh.2004.09.010.
    1. Tsang D, Yeung H, Tso W, Peck H. Ginseng saponins: influence on neurotransmitter uptake in rat brain synaptosomes. Planta Med. 1985;3:221–224. doi: 10.1055/s-2007-969463.
    1. Vuksan V, Sievenpiper J, Koo V, Francis T, Beljan-Zdravkovic U, Xu Z, Vidgen E. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med. 2000;160:1009. doi: 10.1001/archinte.160.7.1009.
    1. Vuksan V, Stavro MP, Sievenpiper JL, et al. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diab Care. 2000;23:1221–1226. doi: 10.2337/diacare.23.9.1221.
    1. Vuksan V, Sievenpiper J, Wong J, Xu Z, Beljan-Zdravkovic U, Arnason J, Assinewe V, Stavro M, Jenkins A, Leiter L. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. Am J Clin Nutr. 2001;73:753.
    1. Vuksan V, Mi-Kyung S, John LS, Stavro PM, Alexandra LJ, Di Marco B, Kwang-Seung L, Lawrence AL, Ki Yeul N, John TA, Melody C, Asima N. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD. 2008;18:46–56. doi: 10.1016/j.numecd.2006.04.003.
    1. Wesnes K, Warburton D. Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology. 1984;82:147–150. doi: 10.1007/BF00427761.
    1. Zhang Y, Liu T. Influences of ginsenosides Rb1 and Rg1 on reversible focal brain ischemia in rats. Zhongguo Yao Li Xue Bao. 1996;17:44–48.
    1. Zhang J, Qu Z, Liu Y, Deng H. Preliminary study on antiamnesic mechanism of ginsenosides Rg1 and Rb1. China Med J. 1990;103:932–938.
    1. Zhu S, Zou K, Fushimi H, Cai S, Komatsu K. Comparative study on triterpene saponins of Ginseng drugs. Planta Med. 2004;70:666–677. doi: 10.1055/s-2004-827192.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren